ARCHIVES

DC Board Okay One Recompetition, Disapproves Two

This article is from The Cancer Letter archive.

Vol. 08 No. 44 | November 12, 1982

Download PDF Visit The Full Archive

Related Articles

Phase III Data of Antibody-Drug Conjugate Shows PFS Increase in HER2+ Disease

June 29, 2012

As For-Profits Provide Phase I Studies, NCI Seeks to Look Deeper and Learn More

April 6, 2012

NCI CTEP Approved Trials For the Month of May

May 31, 2013

In Brief: DeVita, FDA Chief Help Kill California Bill Legalizing Laetrile Wit committee Testimony

August 26, 1977

Stronger Anti-Smoking Efforts Needed For Women, SG Says.

March 30, 2001

Critics of FDA misunderstand Bayesian analysis, statisticians say.

August 5, 2005